Medis’ Quantitative Flow Ratio (QFR®) has been awarded with a Class I recommendation in 3 distinct categories of the 2024 ESC guidelines for the management of patients suffering from chronic coronary syndrome (CCS). This recognition recommends QFR® as a physiology measurement technique next to, and at par with, the traditional wire-based methods. The guidelines also differentiate Medis QFR® from other Angiography-based FFR techniques, which have been called out with a lower IIb/C recommendation, in only one of the 3 categories.
Read MoreMedis’ Quantitative Flow Ratio (QFR®) has been awarded with a Class I recommendation in 3 distinct categories of the 2024 ESC guidelines for the management of patients suffering from chronic coronary syndrome (CCS). This recognition recommends QFR® as a physiology measurement technique next to, and at par with, the traditional wire-based methods. The guidelines also differentiate Medis QFR® from other Angiography-based FFR techniques, which have been called out with a lower IIb/C recommendation, in only one of the 3 categories.
Read MoreSince its foundation in 1989, Medis has been deeply involved in X-ray imaging, particularly 2D and 3D QCA (Quantitative Coronary Angiography), with solutions used worldwide, particularly in Japan. Given the increasing clinical interest in coronary physiology globally, the Medis’ Applied Research team in Leiden, the Netherlands, began exploring a new solution in 2013.
Read MoreToday, GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Medis Medical Imaging, a leading cardiac imaging software company, announced their collaboration aimed at helping advance precision care in the diagnosis and treatment of coronary artery disease (CAD).
Read MoreWe are excited to officially announce the launch of Medis QFR® 3.0, our latest solution designed to streamline your Cath lab workflow for physiology and morphology assessments of intermediate coronary lesions. This new version will bring innovative features, accessibility from anywhere within the hospital network, and a completely new look & feel.
Read MoreClinical experts will share their experiences with Medis QFR® 3.0 through a combination of presentations and hands-on sessions, and you could interact with them in a friendly and open environment. Be ready to learn how they successfully implemented Medis QFR®, to reach the expected clinical outcomes for better patient care.
Read More– Learn how the newest QFR technology enables coronary physiology analysis in under 30 seconds.
– Understand the role of QFR-IMR as a diagnostic tool for coronary microvascular dysfunction assessment.
– Learn how QFR paves the way for new horizons in treatment options.
Lower values of QFR after complete and successful revascularization is associated with 3-time increase in the risk of subsequent adverse events
Read MoreIn the FAVOR III China trial, we investigated whether utilizing quantitative flow ratio (QFR) guidance in lesion selection for percutaneous coronary intervention (PCI) could improve clinical outcomes compared to standard angiography guidance.
Read MoreWe introduced this new section to share tips across all product lines. By sharing this, we want to transfer the knowledge we receive from you and all your peers and enable the use of Medis software to its full potential.
Read More
